Glenn Hearson
May 5, 2016
Completed IPF Study
Post authorisation Safety Study (PASS) of Esbriet® (Pirfenidone): A Prospective
Observational Registry to Evaluate Long Term Safety in a Real World Setting.
Principle Investigator: Professor Gisli Jenkins